United States · FDA National Drug Code directory
Buspirone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2768_98aa0336-0e99-4d64-a08e-0c96e49edf85
- Product NDC
- 71335-2768
- Form
- TABLET
- Composition / generic term
- buspirone hydrochloride
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200501
- Source listing expiry
- 20261231
Source-listed ingredients
- BUSPIRONE HYDROCHLORIDE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET in 1 BOTTLE (71335-2768-1) · 71335-2768-1
- 30 TABLET in 1 BOTTLE (71335-2768-2) · 71335-2768-2
- 56 TABLET in 1 BOTTLE (71335-2768-3) · 71335-2768-3
- 90 TABLET in 1 BOTTLE (71335-2768-4) · 71335-2768-4
- 180 TABLET in 1 BOTTLE (71335-2768-5) · 71335-2768-5
- 15 TABLET in 1 BOTTLE (71335-2768-6) · 71335-2768-6
- 120 TABLET in 1 BOTTLE (71335-2768-7) · 71335-2768-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →